Broncholytin 5,75 mg/4,6 mg/5 ml syrup България - български - Изпълнителна агенция по лекарствата

broncholytin 5,75 mg/4,6 mg/5 ml syrup

Софарма АД - Производни на опиум и отхаркивающие - 5,75 mg/4,6 mg/5 ml syrup

Bronchocin 5,75 mg/4,60 mg/5 ml syrup  България - български - Изпълнителна агенция по лекарствата

bronchocin 5,75 mg/4,60 mg/5 ml syrup 

Актавис ЕАД - Производни на опиум и отхаркивающие - 5,75 mg/4,60 mg/5 ml syrup 

Tussirol 2,5 mg/1 mg/125 mg/ml syrup България - български - Изпълнителна агенция по лекарствата

tussirol 2,5 mg/1 mg/125 mg/ml syrup

Актавис ЕАД - Производни на опиум и отхаркивающие - 2,5 mg/1 mg/125 mg/ml syrup

Favynd 18 micrograms inhalation powder, hard capsule  България - български - Изпълнителна агенция по лекарствата

favynd 18 micrograms inhalation powder, hard capsule 

boehringer ingelheim international gmbh - Бромид tiotropium - 18 micrograms inhalation powder, hard capsule 

Srivasso 18 microgram inhalation powder, hard capsule България - български - Изпълнителна агенция по лекарствата

srivasso 18 microgram inhalation powder, hard capsule

boehringer ingelheim international gmbh - Бромид tiotropium - 18 microgram inhalation powder, hard capsule

Spiolto Respimat 2,5 microgram/2,5 microgram inhalation solution България - български - Изпълнителна агенция по лекарствата

spiolto respimat 2,5 microgram/2,5 microgram inhalation solution

boehringer ingelheim international gmbh - olodaterol и бромид tiotropium - 2,5 microgram/2,5 microgram inhalation solution

Yanimo Respimat 2,5 microgram/2,5 microgram inhalation solution България - български - Изпълнителна агенция по лекарствата

yanimo respimat 2,5 microgram/2,5 microgram inhalation solution

boehringer ingelheim international gmbh - olodaterol и бромид tiotropium - 2,5 microgram/2,5 microgram inhalation solution

Enteroporc Coli AC Европейски съюз - български - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - Прасета - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Suiseng Diff/A Европейски съюз - български - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - Прасета - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.